Biocore Medical Technologies, Inc.
United StatesFDA applicant, unverified
- Devices
- 4
What Biocore Medical Technologies, Inc. makes
Biocore Medical Technologies, Inc. manufactures medical devices designed for wound care, including hemostatic agents like COLLATEK FOAM, COLLATEK POWDER, and COLLATEK SHEET, as well as hydrogel-based dressings such as COLLATEK HYDROGEL. These products are intended for use in controlling bleeding and promoting wound healing in surgical and trauma settings.
The company’s portfolio is classified under Class II (U) devices in the U.S. and is listed in the FDA’s 510(k) clearance registry. The devices are regulated under the U.S. Food and Drug Administration’s medical device regulations, with each product authorised for its specified clinical applications.
Catalogue
Collatek Foam Ref K012997
Regimes: 510(k) Registry: 510(k)Collatek Powder Ref K012990
Regimes: 510(k) Registry: 510(k)Collatek Sheet Ref K012995
Regimes: 510(k) Registry: 510(k)Collatek Hydrogel Ref K022995
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Biocore Medical Technologies, Inc. have in the registry?
The registry currently lists 4 devices for Biocore Medical Technologies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Biocore Medical Technologies, Inc.'s devices?
Among its 4 most recently registered devices, Biocore Medical Technologies, Inc. has devices listed in FDA 510(k) (4 devices).
What are the newest devices from Biocore Medical Technologies, Inc. in the registry?
The most recently registered devices listed for Biocore Medical Technologies, Inc. include COLLATEK FOAM, COLLATEK POWDER, COLLATEK SHEET and COLLATEK HYDROGEL.